Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1565 (LINC01565)
- Target
- LINC01565
- Molecular classification
- Long non-coding RNA (lncRNA), Intergenic
01
Overview
Long intergenic non-protein coding RNA 1565 (**LINC01565**) is a human long non-coding RNA gene of intergenic class, mapped to chromosome 3q21 (chr3:128292123-128292572, minus strand)[1][4]. It is classified as a lincRNA, predicted to be non-protein coding by most metrics, though some coding potential metrics are intermediate[1]. Its aliases include C3orf27 and GR6. No definitive biological function or disease association has been identified, but as a member of the lncRNA family, LINC01565 may play roles in chromatin organization or regulation of gene expression, similar to other lncRNAs. Literature mentioning LINC01565 is limited and provides no evidence that it serves as a conventional drug target or diagnostic biomarker[1][2][4][6][7].
- Other names
- C3orf27GR6Protein GR6putative GR6 proteinENSG00000198685
02
Biological functions
Chromatin regulation (gene/protein expression via epigenetic mechanisms; general for lncRNAs, not specifically shown for LINC01565)RNA-mediated regulation (functions typical of lncRNAs may include alternative splicing, mRNA stability, transcriptional decoy roles)Other (General lncRNA features are applicable while no specific function has been firmly established for LINC01565)
03
Disease associations
Other (There is no direct literature confirming its involvement in specific disease processes, though lncRNAs in this genomic region are sometimes studied in leukemia and cancer)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1565 (LINC01565).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1565 (LINC01565).